Current COVID-19 booster still produces antibodies that effectively neutralise the new PJ.2.1 variant, even though PJ.2.1 binds cells more tightly and gets into cells with low ACE2 levels more easily than other variants…

Scientists have developed an effective antibody therapy against the HIV-like Simian Immunodeficiency Virus (SIV) in rhesus macaques that permanently blocks SIV infection.